Modern ideas about the influence of the gut microbiome on the persistence of HIV infection
https://doi.org/10.31146/1682-8658-ecg-217-9-195-200
Abstract
About the Authors
A. A. KhryaninRussian Federation
V. K. Bocharova
Russian Federation
E. V. Pushkarev
Russian Federation
References
1. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008 Jul 26;372(9635):293-299. doi: 10.1016/S0140-6736(08)61113-7
2. Deeks S. G., Lewin S. R., Ross A. L. et al.International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat Med. 2016 Aug;22(8):839-850. doi: 10.1038/nm.4108
3. Massanella M., Fromentin R., Chomont N. Residual inflammation and viral reservoirs: alliance against an HIV cure. Curr Opin HIV AIDS. 2016 Mar;11(2):234-241. doi: 10.1097/COH.0000000000000230
4. Zilberman-Schapira G., Zmora N., Itav S. et al. The gut microbiome in human immunodeficiency virus infection. BMC Med. 2016 Jun 3;14(1):83. doi: 10.1186/s12916-016-0625-3
5. Zevin A. S., McKinnon L., Burgener A., Klatt N. R. Microbial translocation and microbiome dysbiosis in HIV-associated immune activation. Curr Opin HIV AIDS. 2016 Mar;11(2):182-190. doi: 10.1097/COH.0000000000000234
6. Uprety P, Patel K, Karalius B. et al. Pediatric HIV/AIDS Cohort Study (PHACS). Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection. Clin Infect Dis. 2017 Jun 1;64(11):1471-1478. doi: 10.1093/cid/cix192
7. Persaud D., Patel K., Karalius B. et al. Pediatric HIV/AIDS Cohort Study. Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents. JAMA Pediatr. 2014 Dec;168(12):1138-1146. doi: 10.1001/jamapediatrics.2014.1560
8. Chun T. W., Nickle D. C., Justement J. S. et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis. 2008 Mar 1;197 (5):714-720. doi: 10.1086/527324
9. Chomont N., El-Far M., Ancuta P. et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009 Aug;15(8):893-900. doi: 10.1038/nm.1972
10. Brenchley J. M., Schacker T. W., Ruff L. E. et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004 Sep 20;200(6):749-759. doi: 10.1084/jem.20040874
11. Mudd J. C., Brenchley J. M. Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression. J Infect Dis. 2016 Oct 1;214 Suppl 2(Suppl 2): S58-66. doi: 10.1093/infdis/jiw258
12. Yukl S. A., Shergill A. K., Ho T. et al. The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence. J Infect Dis. 2013 Oct 15;208(8):1212-1220. doi: 10.1093/infdis/jit308
13. Ananworanich J., Chomont N., Eller L. A. et al. RV217 and RV254/SEARCH010 study groups. HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART. EBioMedicine. 2016 Sep;11:68-72. doi: 10.1016/j.ebiom.2016.07.024
14. Ananworanich J., Sacdalan C. P., Pinyakorn S. et al. Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection. J Virus Erad. 2016;2(1):43-48. PMID: 26889497; PMCID: PMC4754199
15. Rothenberger M. K., Keele B. F., Wietgrefe S. W. et al. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption. Proc Natl Acad Sci USA. 2015 Mar 10;112(10): E1126-34. doi: 10.1073/pnas.1414926112
16. Yukl S. A., Boritz E., Busch M. et al. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog. 2013;9(5): e1003347. doi: 10.1371/journal.ppat.1003347
17. Gantner P., Assoumou L., Leruez-Ville M. et al. EVARIST ANRS EP 49 Study Group. HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens. J Antimicrob Chemother. 2016 Nov;71(11):3202-3205. doi: 10.1093/jac/dkw271
18. Mujugira A., Celum C., Coombs R. W. et al. HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):579-584. doi: 10.1097/QAI.0000000000001019
19. Klatt N. R., Cheu R., Birse K. et al. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science. 2017 Jun 2;356(6341):938-945. doi: 10.1126/science.aai9383
20. Khryanin A. A., Knorring H. Yu., Bocharova V. K. Violation of the vaginal microbiome and the risk of HIV infection in women. HIV Infection and Immunosuppressive Disorders. 2023;15(1):23-31. (In Russ.) doi: 10.22328/2077-9828-2023-15-1-23-31@@ Хрянин А. А., Кнорринг Г. Ю., Бочарова В. К. Нарушение вагинального микробиома и риск заражения ВИЧ-инфекцией у женщин. ВИЧ-инфекция и иммуносупрессии. 2023;15(1):23-31. doi: 10.22328/2077-9828-2023-15-1-23-31
21. Wong J. K., Yukl S. A. Tissue reservoirs of HIV. Curr Opin HIV AIDS. 2016 Jul;11(4):362-370. doi: 10.1097/COH.0000000000000293
22. Dillon S. M., Lee E. J., Donovan A. M. et al. Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection. Retrovirology. 2016 Jan 14;13:5. doi: 10.1186/s12977-016-0237-1
23. Dubourg G., Lagier J. C., Hüe S. et al. Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygen. BMJ Open Gastroenterol. 2016 Jul 28;3(1): e000080. doi: 10.1136/bmjgast-2016-000080
24. Gootenberg D. B., Paer J. M., Luevano J. M., Kwon D. S. HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation. Curr Opin Infect Dis. 2017 Feb;30(1):31-43. doi: 10.1097/QCO.0000000000000341
25. Villanueva-Millán M.J., Pérez-Matute P., Recio-Fernández E. et al. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients. J Int AIDS Soc. 2017 Mar 9;20(1):21526. doi: 10.7448/IAS.20.1.21526
26. Khryanin A. A., Osipenko M. F., Nemchaninova O. B. et al. Strategies for restoring the intestinal mucosal barrier. Experimental and clinical gastroenterology. 2021;1(6):88-95. (In Russ.) doi.: 10.31146/1682-8658-ecg-190-6-88-95.@@ Хрянин А. А., Осипенко М. Ф., Немчанинова О. Б. и др. Стратегии восстановления слизистого барьера кишечника. Экспериментальная и клиническая гастроэнтерология. 2021;1(6):88-95. doi.: 10.31146/1682-8658-ecg-190-6-88-95.
27. Garrett W. S., Gallini C. A., Yatsunenko T. et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe. 2010 Sep 16;8(3):292-300. doi: 10.1016/j.chom.2010.08.004
28. Armstrong A. J.S., Shaffer M., Nusbacher N. M. et al. An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men. Microbiome. 2018 Nov 5;6(1):198. doi: 10.1186/s40168-018-0580-7
29. Lu W., Feng Y., Jing F. et al. Association Between Gut Microbiota and CD4 Recovery in HIV-1 Infected Patients. Front Microbiol. 2018 Jul 2;9:1451. doi: 10.3389/fmicb.2018.01451
30. Lee S. C., Chua L. L., Yap S. H. et al. Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals. Sci Rep. 2018 Sep 24;8(1):14277. doi: 10.1038/s41598-018-32585-x
31. Ling Z., Jin C., Xie T. et al. Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population. Sci Rep. 2016;6:30673. doi: 10.1111/jcmm.13508
32. Larsen J. M. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017 Aug;151(4):363-374. doi: 10.1111/imm.12760. Epub 2017 Jun 20
33. Jiang F., Meng D., Weng M. et al. The symbiotic bacterial surface factor polysaccharide A on Bacteroides fragilis inhibits IL-1β-induced inflammation in human fetal enterocytes via toll receptors 2 and 4. PLoS One. 2017 Mar 9;12(3): e0172738. doi: 10.1371/journal.pone.0172738
34. Noguera-Julian M., Rocafort M., Guillén Y. et al. Gut Microbiota Linked to Sexual Preference and HIV Infection. EBioMedicine. 2016 Jan 28;5:135-146. doi: 10.1016/j.ebiom.2016.01.032
35. Pinto-Cardoso S., Lozupone C., Briceño O. et al. Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens. Sci Rep. 2017 Mar 6;7: 43741. doi: 10.1038/srep43741
36. Nowak R. G., Bentzen S. M., Ravel J. et al. TRUSTRV368 Study Group. Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria. AIDS. 2017 Mar 27;31(6):857-862. doi: 10.1097/QAD.0000000000001409
37. Winter S. E., Winter M. G., Xavier M. N. et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science. 2013 Feb 8;339(6120):708-711. doi: 10.1126/science.1232467
38. Winter S. E., Thiennimitr P., Winter M. G. et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010 Sep 23;467(7314):426-429. doi: 10.1038/nature09415
39. Deleage C., Schuetz A., Alvord W. G. et al. Impact of early cART in the gut during acute HIV infection. JCI Insight. 2016 Jul 7;1(10): e87065. doi: 10.1172/jci.insight.87065
40. Mahjoub-Messai F., Bidet P., Caro V. et al. Escherichia coli isolates causing bacteremia via gut translocation and urinary tract infection in young infants exhibit different virulence genotypes. J Infect Dis. 2011 Jun 15;203(12):1844-1849. doi: 10.1093/infdis/jir189
41. Bender J. M., Li F., Martelly S. et al. Maternal HIV infection influences the microbiome of HIV-uninfected infants. Sci Transl Med. 2016 Jul 27;8(349):349ra100. doi: 10.1126/scitranslmed.aaf5103
42. Vesterbacka J., Rivera J., Noyan K. et al. Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers. Sci Rep. 2017 Jul 24;7(1):6269. doi: 10.1038/s41598-017-06675-1
43. Hoenigl M., Pérez-Santiago J., Nakazawa M. et al. (1→3)-β-d-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection? Front Immunol. 2016 Oct 3;7:404. doi: 10.3389/fimmu.2016.00404
44. Serrano-Villar S., Rojo D., Martínez-Martínez M. et al. Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals. EBioMedicine. 2016 Jun;8:203-216. doi: 10.1016/j.ebiom.2016.04.033
45. Rivière A., Selak M., Lantin D. et al. Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut. Front Microbiol. 2016 Jun 28;7:979. doi: 10.3389/fmicb.2016.00979
46. Imai K., Yamada K., Tamura M. et al. Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria. Cell Mol Life Sci. 2012 Aug;69(15):2583-2592. doi: 10.1007/s00018-012-0936-2
47. Bolduc J. F., Hany L., Barat C. et al. Epigenetic Metabolite Acetate Inhibits Class I/II Histone Deacetylases, Promotes Histone Acetylation, and Increases HIV-1 Integration in CD4+ T Cells. J Virol. 2017 Jul 27;91(16): e01943-16. doi: 10.1128/JVI.01943-16
48. Rasmussen T. A., Lewin S. R. Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents? Curr Opin HIV AIDS. 2016 Jul;11(4):394-401. doi: 10.1097/COH.0000000000000279
49. Lee C. H., Steiner T., Petrof E. O. et al. Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. JAMA. 2016 Jan 12;315(2):142-149. doi: 10.1001/jama.2015.18098
50. Vujkovic-Cvijin I., Rutishauser R. L., Pao M. et al. Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals. Gut Microbes. 2017 Sep 3;8(5):440-450. doi: 10.1080/19490976.2017.1334034
51. Hensley-McBain T., Zevin A. S., Manuzak J. et al. Effects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2016 Apr 29;90(10):4981-4989. doi: 10.1128/JVI.00099-16
Review
For citations:
Khryanin A.A., Bocharova V.K., Pushkarev E.V. Modern ideas about the influence of the gut microbiome on the persistence of HIV infection. Experimental and Clinical Gastroenterology. 2023;(9):195-200. https://doi.org/10.31146/1682-8658-ecg-217-9-195-200
Email this article 